Navigation Links
Epileptic Drug Found To Be Efficient As A Single Therapy

A study conducted by the scientists at Western Infirmary Epilepsy Unit in Glasgow, //confirmed that drug levetiracetam is effective as a single therapy. This study was published in the journal Neurology.

This was a double-blind study which had around six hundred participants who had suffered at least two attacks of convulsions in the last year to the drug levetiracetam or to controlled release carbamazepine which is considered as the usual therapy for epilepsy.

Generally levetiracetam is used in combination with other drugs. But this is the first time it was tested as a lone therapy. It was found that 72.8% of people who had received carbamazepine did not have epileptic attack for six months while it was 73% for levetiracetam users.

Dr Martin Brodie who is the lead scientist of this study opines that levetiracetam has an edge over other epileptic drugs as it is proved to be a safe and user friendly drug. This study also emphasizes the fact that epileptic patients react better to the drug that is given to them first at low dosage levels.


Page: 1

Related medicine news :

1. Epileptic Seizures Can Be Due to Heart Problem
2. Epileptic Drug Found To Be Effective In Relieving Headache
3. Brain Septum Could Help In reducing Epileptic Seizures
4. Father Who Killed Epileptic Son Says He Misses Him
5. Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts
6. Light-activated Compound May Be of Help for Epileptics in Future
7. Anti-Epileptic Drug Intake May Result In Children With Mental Retardation
8. Fluoride Found Effective in Osteoporosis
9. Implantable Contact Lens Found Safe and Effective
10. Cancer hazard Found With Animal-Based Nutrients
11. Processed Meat, Diabetes connection Found
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced that ... Business Awards under the New Products and Services category for its innovative product ... management software that helps labs organize data and track samples with storage ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, ... a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program ... as a finalist in the category of Digital Solutions for its innovative, industry-leading ...
(Date:12/1/2015)... ... 01, 2015 , ... TCS Healthcare Technologies (TCS), a leading ... arenas, is pleased to announce that VIP Care Services, a Caprock Health Group ... ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... , December 1, 2015 --> ... report "Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, ... Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020", ... to reach USD 73,529.2 Million by 2020 from USD 40,281.6 ... to 2020. Browse 37 ...
(Date:12/1/2015)... HERTFORDSHIRE, England , BANGALORE, India ... 2015  Mylan N.V. (NASDAQ, TASE: MYL) today announced ... upon regulatory approval and for developing country markets funded ... + Lamivudine 300 mg + Efavirenz 400 mg) for ... Clinton Health Access Initiative (CHAI) to develop TLE400. The ...
Breaking Medicine Technology: